Literature DB >> 8870114

Outcome of silent lupus nephritis.

M R Gonzalez-Crespo1, J I Lopez-Fernandez, G Usera, M J Poveda, J J Gomez-Reino.   

Abstract

To analyze the long-term outcome in patients with silent lupus nephritis, we retrospectively studied 20 patients with systemic lupus erythematosus without clinical renal involvement who had renal biopsies in our unit between 1978 and 1986 and reviewed 193 cases reported between 1957 and 1995. Two patients of the current series were lost to follow-up. Mean follow-up in the other 18 was 13 +/- 3 years (range, 2 to 17). On kidney biopsy, nine had class I, six class II, one class IV, and two class V disease (WHO classification). Three patients with prior normal renal function died of nonrenal causes. During the study, the remaining 15 patients had normal renal function and urinalysis. Most patients from the literature had "mild" histologic lesions, but 30 had diffuse proliferative glomerulonephritis. Over an average of 46 months of follow-up from biopsy, renal survival rate and patient survival rate were 98% and 91%, respectively. Three patients died of end-stage renal failure. In conclusion, end-stage renal failure in patients with silent lupus nephritis is rare regardless of the histopathological renal lesions. Patients survival depends on nonrenal causes.

Entities:  

Mesh:

Year:  1996        PMID: 8870114     DOI: 10.1016/s0049-0172(96)80027-8

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  11 in total

1.  Survival study by organ disorders in 306 Japanese patients with systemic lupus erythematosus: results from a single center.

Authors:  M Funauchi; H Shimadzu; C Tamaki; T Yamagata; Y Nozaki; M Sugiyama; S Ikoma; K Kinoshita
Journal:  Rheumatol Int       Date:  2006-08-31       Impact factor: 2.631

Review 2.  Lupus nephritis: an update.

Authors:  Tasnim F Imran; Frederick Yick; Suneet Verma; Christopher Estiverne; Chinonye Ogbonnaya-Odor; Srikanth Thiruvarudsothy; Alluru S Reddi; Neil Kothari
Journal:  Clin Exp Nephrol       Date:  2015-10-16       Impact factor: 2.801

3.  Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis.

Authors:  Tamar Rubinstein; Milena Pitashny; Benjamin Levine; Noa Schwartz; Julie Schwartzman; Elena Weinstein; Jose M Pego-Reigosa; Tim Y-T Lu; David Isenberg; Anisur Rahman; Chaim Putterman
Journal:  Rheumatology (Oxford)       Date:  2010-02-09       Impact factor: 7.580

4.  Sisters with alpha-mannosidosis and systemic lupus erythematosus.

Authors:  Maki Urushihara; Shoji Kagami; Koji Yasutomo; Michinori Ito; Shuji Kondo; Akiko Kitamura; Dag Malm; Helle Klenow; Oivind Nilssen; Yasuhiro Kuroda
Journal:  Eur J Pediatr       Date:  2004-02-04       Impact factor: 3.183

Review 5.  Membranous nephropathy in systemic lupus erythematosus: a therapeutic enigma.

Authors:  Chi Chiu Mok
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

6.  Urinary Albumin Levels are Independently Associated with Renal Lesion Severity in Patients with Lupus Nephritis and Little or No Proteinuria.

Authors:  Jin Ding; Zhaohui Zheng; Xueyi Li; Yuan Feng; Nan Leng; Zhenbiao Wu; Ping Zhu
Journal:  Med Sci Monit       Date:  2017-02-03

7.  The potential diagnostic utility of coexpression of Ki-67 and P53 in the renal biopsy in pediatric lupus nephritis.

Authors:  Mahtab H Rahbar; Maryam R Rahbar; Nyousha Mardanpour; Sourena Mardanpour
Journal:  Int J Nephrol Renovasc Dis       Date:  2018-12-12

8.  Chapter 12: Lupus nephritis.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2012-06

9.  An unusual initial presentation of lupus nephritis as a renal mass.

Authors:  Remi Goupil; Annie-Claire Nadeau-Fredette; Virginie Royal; Alexandre Dugas; Jean-Philippe Lafrance
Journal:  Case Rep Nephrol       Date:  2015-01-08

10.  Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis.

Authors:  Oh Chan Kwon; Jung Hwan Park; Hyeong-Cheon Park; Seung Min Jung; Sang-Won Lee; Jason Jungsik Song; Yong-Beom Park; Min-Chan Park
Journal:  Arthritis Res Ther       Date:  2020-06-09       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.